The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
J Miss State Med Assoc
; 37(10): 777-9, 1996 Oct.
Article
em En
| MEDLINE
| ID: mdl-8908950
ABSTRACT
PIP: The effect of postpartum Norplant implant use on coagulation factors was investigated in a prospective study conducted in Mississippi, US. 85 postpartum women were given a choice of 3 contraceptive methods: levonorgestrel implants (n = 25), oral contraceptives (n = 38), or a barrier method (n = 22). Antithrombin-III (AT-III) levels were measured on the day of discharge from the hospital after delivery, 7 days after delivery, and 6 weeks after delivery. There was no significant difference between groups in the initial AT-III level (mean, 100.35 +or- 1.61%). At the end of the first postpartum week, AT-III levels rose significantly to 109.1 +or- 1.89%, but again, there were no significant differences according to contraceptive method. By the 6-week follow-up, AT-III levels had stabilized at a mean of 105.51 +or- 1.71%, with no significant between-group differences. AT-III levels in pill users declined more markedly between the first and sixth postpartum weeks than those in the 2 other groups. These findings indicate that subdermal implant use does not affect coagulation, and these devices can be inserted safely during the postpartum period.
Palavras-chave
Americas; Biology; Blood Coagulation Effects--women; Comparative Studies; Contraception; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Developed Countries; Family Planning; Hematological Effects; Hemic System; Levonorgestrel--pharmacodynamics; North America; Northern America; Physiology; Postpartum Women; Puerperium; Reproduction; Research Methodology; Research Report; Studies; United States; Women
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Coagulação Sanguínea
/
Antitrombina III
/
Levanogestrel
/
Anticoncepcionais Femininos
Tipo de estudo:
Observational_studies
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Ano de publicação:
1996
Tipo de documento:
Article